ZIMV240719C12500
- 5.90
- 0.000.00%
ZimVie Newsroom
ZimVie to Report Second Quarter Financial Results on August 1, 2024
PALM BEACH GARDENS, Fla., July 18, 2024 (GLOBE NEWSWIRE) -- ZimVie Inc. (NASDAQ:ZIMV), a global life sciences leader in the dental market, today announced it will report financial results for the second quarter 2024
Why Domino's Pizza Shares Are Trading Lower By Over 11%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Shares of Domino's Pizza, Inc. (NYSE:DPZ) fell sharply during Thursday's session after the company reported mixed quarterly results.The company reported second-quarter FY24 sales growth of 7.1% year-
Cintas Posts Upbeat Earnings, Joins CommScope Holding, Virtu Financial And Other Big Stocks Moving Higher On Thursday
U.S. stocks were higher, with the Dow Jones index gaining around 150 points on Thursday.Shares of Cintas Corporation (NASDAQ:CTAS) rose during Thursday's session after the company reported better-
ZimVie Stock Rises on Reports of Advanced Sale Talks
Market Chatter: ZimVie in Advanced Acquisition Talks With Osstem
ZimVie (ZIMV) is in advanced talks with dental implant maker Osstem Implant, which has submitted a final bid to acquire ZimVie, Bloomberg News reported Thursday, citing people familiar with the
ZimVie (ZIMV.US) rose more than 14% before trading, and it is reported that South Korean dental implant manufacturer Osstem is interested in acquiring it.
According to informed sources, dental implant manufacturer Osstem Implant Co. is in deep negotiations to acquire its counterpart ZimVie, which is listed in New York.
ZimVie Jumps After Report on Buyout Talks With South Korea's Osstem
ZimVie Reportedly Considers Sale, Alternative Options
ZimVie May Be Worth $25-$29 a Share in Takeover -analyst
Sector Update: Health Care
Health care stocks were softer Tuesday afternoon, with the NYSE Health Care Index shedding 0.2% and the Health Care Select Sector SPDR Fund (XLV) down 0.3%. The iShares Biotechnology ETF (IBB) eased 0
Needham Maintains ZimVie(ZIMV.US) With Buy Rating, Maintains Target Price $20
Needham analyst David Saxon maintains $ZimVie(ZIMV.US)$ with a buy rating, and maintains the target price at $20.According to TipRanks data, the analyst has a success rate of 36.0% and a total average
Express News | ZimVie Shares Are Trading Higher Following a Report Suggesting That the Company Is Considering a Potential Sale
Express News | Needham Reiterates Buy on ZimVie, Maintains $20 Price Target
Express News | Watching ZimVie; Needham Issues Note Titled "Reportedly Fielding Takeout Offers"; Estimates That ZIMV Could Be Worth $25-$29 Per Share In A Potential Acquisition
ZimVie Mulling Sale, Other Options After Receiving New Takeover Approaches, Bloomberg Says
11:36 AM EDT, 06/25/2024 (MT Newswires) -- ZimVie Mulling Sale, Other Options After Receiving New Takeover Approaches, Bloomberg Says Price: 17.30, Change: +2.51, Percent Change: +16.97
Dental Implant Maker ZimVie Jumps After Report It's Evaluating Sale
Express News | ZimVie Is Said To Weigh Options Amid Fresh Takeover Interest
12 Health Care Stocks Moving In Friday's Pre-Market Session
GainersAkanda (NASDAQ:AKAN) shares rose 177.7% to $0.37 during Friday's pre-market session. The company's market cap stands at $11.7 million. Scorpius Holdings (AMEX:SCPX) stock increased by 28.17% to
ZimVie to Participate in Upcoming Investor Conferences
PALM BEACH GARDENS, Fla., May 16, 2024 (GLOBE NEWSWIRE) -- ZimVie Inc. (NASDAQ:ZIMV), a global life sciences leader in the dental market, today announced that the company will be participating in two upcoming investor
Express News | ZimVie Inc : Needham Raises to Buy From Hold